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Abstract
Use of transcranial Doppler has undergone much development since its introduction in 1982, making the technique 
suitable for general use in  intensive care units. The main application in intensive care units is to assess intracranial 
pressure, confirm the lack of cerebral circulation in brain death, detect vasospasm in subarachnoid haemorrhage, 
and monitor the blood flow parameters during thrombolysis and carotid endarterectomy, as well as measuring ste-
nosis of the main intracranial arteries in sickle cell disease in children. 
This review summarises the use of transcranial Doppler in intensive care units.
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 Introduction
Transcranial Doppler (TCD) was developed originally 
to detect vasospasm after subarachnoid haemorrhage 
[1]. However, since its launch in 1982, its use has wid-
ened to  include diagnosis of stenosis or occlusion of 
the main intracranial arteries, measurement of cer-
ebrovascular reserve capacity, examination of autoreg-
ulation and neurovascular coupling, microembolus 
detection and thus diagnosis of right-to-left shunt, 
ultrasound enhanced thrombolysis, assessment of in-
creased intracranial pressure (ICP), detection of stop 
of brain circulation in brain death, and monitoring of 
cerebral circulation during carotid surgery or stenting, 
as well as during heart surgery. Moreover, development 
of transcranial colour-coded duplex (TCCD) exami-
nation allows the investigation of the cerebral paren-
chyma, the size of brain ventricles, and a more precise 
analysis of blood flow in the intracranial arteries. TCD 
is now extensively used in neurological disorders re-
quiring intensive therapy. 
The aim of this review is to summarise the potential 
applications of TCD and TCCD in intensive care units.
 The Basics of TCD
TCD uses relatively low frequency (2.0-2.5 MHz) ul-
trasound,  as ultrasound at this frequency penetrates 
through the thinner parts of the skull, known as “bone 
windows”. The ophthalmic artery and the carotid sy-
phon can be viewed through the eye, the main intrac-
ranial arteries through the trans-temporal window, and 
the vertebral arteries and the basilar artery through the 
foramen magnum. The flow velocity in the extracranial 
part of the internal carotid artery used for calculation 
of the Lindegaard index in subarachnoid haemorrhage 
can be determined using a submandibular approach 
[2].
TCD examination allows the determination of flow 
velocity in the main vessels as well as the pulsatility in-
dex. It is important to emphasise that flow velocity in 
different individuals is not proportional to the blood 
flow, though flow velocity changes in one individual re-
flect the flow variations in the region of the insonated 
vessel [3, 4]. The pulsatility index (PI) is calculated us-
ing the ratio of the difference of peak systolic (PSV) 
and end-diastolic flow velocity (EDV) and the mean 
flow velocity (MV) i.e. PI = (PSV-EDV)/MV. [5]  PI is 
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a useful parameter for assessing the vascular resistance 
in the region of an insonated artery. With the use of 
head frames, TCD probes can be fixed to allow the con-
tinuous monitoring of flow parameters.
 Intracranial Pressure and TCD
Since the brain is enclosed in a rigid cavity, increase 
in the volume of any intracranial element leads to in-
creased intracranial pressure. TCD is suitable for as-
sessing intracranial pressure reducing the need for in-
vasive measurement. 
Increased intracranial pressure can be caused by 
cytotoxic or vasogenic oedema, tumors, hydroceph-
alus, and cerebral haemorrhage. An increase in in-
tracranial pressure, more than the venous pressure, 
results in compression of veins and thus decreased 
venous outflow. Increase in ICP is accompanied by an 
increase in PI due to a decrease in diastolic and mean 
velocities [6].
PI larger than 1.26 was shown to be associated with 
an intracranial pressure more than 20 cm H2O (sensi-
tivity 81.1%, specificity 96.3% [7]. Bouzat et al. (2011) 
showed that low end-diastolic flow velocity (<25 cm/s; 
sensitivity 92%, specificity 76%) and high PI (>1.25; 
sensitivity 90%, specificity 91%) indicated increased 
risk of secondary neurological deterioration in patients 
with mild to moderate traumatic brain injury with no 
severe brain lesions on CT [8]. Despite these data, pul-
satility index alone does not seem to be a reliable pre-
dictor for intracranial pressure, but there is evidence 
that the autoregulatory index (Mx) derived from blood 
flow velocity and arterial blood pressure measured 
non-invasively, is a useful parameter for assessing in-
creased intracranial pressure in traumatic brain injury. 
Although more sophisticated analysis is necessary for 
assessment of dynamic cerebral autoregulation, poorer 
autoregulation was proven to be associated with poorer 
outcome and greater mortality in traumatic brain in-
jury. Sorrentino et al. (2011) found that an autoregula-
tion index (Mx) of more than 0.3 clearly indicated dis-
turbed autoregulation [9].
A significant correlation was shown between PI and 
ICP (CC = 0.938). Regression statistics revealed that 
the ICP value could be determined from the PI (ICP = 
11.1 x  PI − 1.43) with an error of ±4.2 mmHg compa-
red to the actual ICP measured by an invasive method. 
ICP of more than 20 mmHg was established with 89% 
sensitivity and 92% specificity [10]. 
In another study, a PI ≥1.56 in patients with trauma-
tic brain injury predicted a poor outcome at six months, 
while a PI ≤1 identified patients with a favourable out-
come [11].
At present, changes in pulsatility index values rather 
than absolute values can be used to assess an increase 
in ICP. Monitoring of flow parameters by TCD allows 
changes in PI to be monitored and a  1 mmHg change 
in ICP was shown to equate to a PI change of 2.4% [12].
 Optic nerve sheath diameter and 
increased intracranial pressure
In addition to flow parameters and auto-regulatory 
index, a more reliable indicator of increased intracra-
nial pressure, namely the optic nerve sheath diameter 
(ONSD) has been widely used in the last decade. Al-
though measurement of ONSD is based on B-mode ul-
trasound, and not on TCD, we consider it is important 
to describe this technique briefly. 
The subarachnoid space surrounds the optic nerve 
and is bounded by the optic nerve sheath that is an ana-
tomical extension of the dura mater. It is well known 
that an increase in the intracranial pressure results in 
swelling of the optic disc, i.e. papilla-oedema. How-
ever, development of papilla-oedema takes time, as is, 
therefore, a delayed indicator of increased intracranial 
pressure. Dilatation of the optic nerve sheath has been 
described as an early manifestation of a rise in intrac-
ranial pressure (Figure 1). [13, 14, 15] The optic nerve 
sheath can be examined by B-mode ultrasound with 
use of 7-11 MHz. ultrasound probe. The cut-off value 
for normal ONSD, measured at three mm posterior to 
the eye, ranges from 5.2 to 5.9 mm [15]. Although there 
is a relatively wide variation in the optimal cut-off val-
ues for normal ONSD [16,17], it seems to be a sensitive 
test for predicting elevated ICP. During the examina-
tion, the mechanical index has to decrease as little as 
possible, and the probe has to be placed lightly on the 
eyelids. The method cannot be used in patients with 
eye trauma or glaucoma [18]. Moreover, ONSD should 
not be considered in isolation, but must form part of a 
holistic approach towards the management of a patient 
with possible intracranial hypertension.
 TCD in brain death
Brain death is defined as an irreversible cessation of 
brain stem functions that is associated with cerebral 
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circulatory arrest caused by increased intracranial 
pressure. TCD is used as a confirmatory test to authen-
ticate lack of cerebral blood flow.
With increasing ICP, TCD waveform shows high-
resistance profiles. At first, the diastolic flow velocity 
decreases then becomes zero, and if the intracranial 
pressure increases further, flow reversal occurs dur-
ing diastole [19]. As cerebral perfusion pressure ap-
proaches zero, oscillating flow and small systolic spikes 
may appear (Figure 2), and finally no signal is detected 
[19,20]. Oscillating MCA flow pattern is characterised 
by equal systolic forward flow and diastolic reversed 
flow, i.e. net zero flow, indicating raised ICP and brain 
death. Systolic spikes of <200 ms duration and <50 cm/s 
PSV with no diastolic flow, as well as lack of flow, pro-
ves lack of cerebral circulation.
Once oscillating flow is identified, it should be pre-
sent in both MCAs and the basilar artery and should 
be registered at two different time points, with a time 
interval of 30 minutes, to exclude effects of a transient 
increase in intracranial pressure. TCD alone is not suit-
able for diagnosing brain death but may shorten the 
duration of the observation period.
 TCD detection of vasospasm caused 
by subarachnoid haemorrhage (SAH)
In non-traumatic SAH due to a ruptured intracranial 
aneurysm, the primary causes of morbidity are re-
bleeding and cerebral vasospasm [21-23]. Vasospasm 
is caused by the release of haemoglobin and its break-
down products into the CSF [24, 25]. Vasoconstric-
tion of the main intracranial arteries, leading to del-
ayed ischemic damage, was shown to have a significant 
effect on mortality and morbidity [26]. Vasospasm fol-
lowing SAH most commonly develops after the second 
day and reaches a maximum at the end of the second 
week [27-29]. Daily TCD is recommended in all cases 
of SAH, 3-10 days after the onset of the disease. Serial 
TCD measurements can be stopped two  weeks after 
the beginning of SAH, if vasospasm does not develop 
in this period. Otherwise, daily TCD measurements 
should be performed until the vasospasm resolves.  The 
aim of TCD is to identify early development of a sig-
nificant vasospasm and to start appropriate treatment 
to avoid delayed ischemic deficits.
Vasospasm results in increased flow velocity in the 
affected artery. However, increase in MFV might also 
be caused by stenosis or hyperaemia. Increased flow ve-
locity due to stenosis usually affects smaller segments 
of the artery, while vasospasm results in flow velocity 
increase in longer arterial segments. The Lindegaard 
ratio, defined as MFV in MCA / MFV in extracranial 
ICA, differentiates between hyperaemic flow and va-
sospasm [30]. While hyperaemic flow is associated with 
higher ICA and MCA flow velocities, vasospasm due to 
SAH results in flow velocity increase only in intracra-
nial, but not in extracranial arteries, meaning that hy-
peraemic flow does not influence the Lindegaard ratio 
significantly. However, in vasospasm, an increase in the 
Lindegaard ratio is expected. MFV and the Lindegaard 
ratio are suitable to grade the severity of vasospasm. 
Criteria for vasospasm in SAH were established for 
Fig. 1. The subarachnoid space surrounds the optic nerve 
and is bounded by the optic nerve sheath that is an ana-
tomical extension of the dura mater around the nerve. 
In case of increased intracranial pressure (ICP), the optic 
nerve sheath is dilated due to the elevated cerebrospinal 
fluid (CSF) pressure.
Fig. 2. Systolic spikes detected in the right MCA in brain 
death.
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MCA and BA (Table 1), but are less reliable for ACA 
and PCA.
 Thrombolysis and TCD
TCD and TCCD are useful tools for diagnosing the oc-
clusion of main intracranial arteries. Moreover, TCD 
with monitoring probes fixed by a headband is suitable 
for monitor spontaneous or treatment-induced reca-
nalization [31, 32]. Ultrasound was shown to loosen fi-
brin bridges resulting in thrombi being dissolved [33]. 
Although smaller studies suggested that insonation 
with TCD may augment the lytic effect of the rt-PA 
[32,34], the CLOTBUST trial failed to confirm a sig-
nificant clinical benefit, measured at 90 days,  of rt-PA 
treatment and the additional use of low power ultra-
sound compared to the rt-PA treatment alone [35].
 Stenosis of the main intracranial 
arteries caused by sickle cell disease
Circulating sickled cells and their adherence to the en-
dothelial cells increase the risk of stenosis and occlusion 
of the main intracranial arteries, including ICA, MCA 
and ACA [36]. Because the time-averaged mean of the 
maximum velocity above 170-200 cm/s in the middle 
cerebral artery was associated with an increased risk of 
stroke [37],  and beneficial effect of blood transfusion 
could reduce  the risk of stroke significantly [38], TCD 
screening is extremely useful in children with sickle 
cell disease.
 Monitoring of MCA flow during 
carotid endarterectomy
During carotid endarterectomy, the CCA on the side 
of the surgery is clamped for the period of disoblitera-
tion. However, in case of poor collateral circulation, 
this type of artificial occlusion of the CCA may result 
in significant hypoperfusion and stroke. There are sev-
eral methods to monitor the safety of CCA clamping, 
including local anaesthesia, somatosensory evoked po-
tential and TCD monitoring. At least 30% decrease of 
MCA MFV after clamping of CCA indicates a signifi-
cant reduction in cerebral flow. Lack of normalisation 
of the MCA MFV within 1-2 minutes suggests reduced 
collateral cerebral circulation and the need for shunt-
ing during carotid endarterectomy [39, 32].
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